A new minority staff fact sheet summarizes the numerous special-interest provisions buried in the homeland security bill (H.R. 5710) that limit the liability of drug companies, airline carriers, airline security companies, and other manufacturers. Rep. Waxman writes OMB Director Daniels to inquire about the provisions that would change the Vaccine Injury Compensation Program in a way that benefits manufacturers Eli Lilly and Dow Chemical, and to HHS Secretary Thompson to call his attention to the provisions that provide liability protection for makers of the smallpox vaccine, yet fail to provide appropriate compensation for those who may be injured by the vaccine.